ArticleJACC. Case reports2025
Coronary Artery Supply to a Cardiac Mass.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCoronary artery perfusion of cardiac tumors is rare but carries diagnostic and therapeutic implications. CASE SUMMARY: A 43-year-old incarcerated male with SDHD gene-associated hereditary paraganglioma-pheochromocytoma syndrome presented with dyspnea and leg edema. Computed tomography and cardiac magnetic resonance imaging revealed a vascular intrapericardial mass in the aortopulmonary window encasing major vessels. Left heart catheterization showed arterial supply from the left anterior descending and right coronary arteries. Given the vascular complexity of the pericardial mass, surgery was deferred. The patient was managed medically and was discharged with plans for I-131 metaiodobenzylguanidine and chemotherapy. Advanced imaging confirmed somatostatin-avid metastases. DISCUSSION: This case demonstrates the value of multimodal imaging in evaluating coronary-perfused cardiac tumors. It also illustrates the systemic nature of diseases associated with SDHD gene pathology. Delayed follow-up during incarceration highlights a health equity concern, as incarcerated individuals often face barriers to specialty care. TAKE-HOME MESSAGES: Cardiac tumors with coronary perfusion require advanced imaging. Addressing disparities in vulnerable populations is essential for equitable outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.